Martin VanTrieste

He was the former chief quality officer at Amgen. Prior to joining Amgen, Mr. VanTrieste was with Bayer Healthcare’s Biological Products Division as vice president of worldwide quality and Abbott Laboratories as the vice president of quality assurance for the Hospital Products Division.

Mr. VanTrieste is the founder of Rx-360, an international nonprofit organization that enhances patient safety by increasing security and quality in the biopharmaceutical supply chain. He has also served as the Chairman and Board Member of the Parenteral Drug Association (PDA) Board of Directors.

PharmaVoice has named Mr. VanTrieste one of the 100 most inspiring people in the pharmaceutical industry, calling him “a man with a mission.” The Medicine Maker has previously named him one of the most influential people in the world of drug development and manufacture saying he “is known throughout industry as a change agent and influencer for his work on advancing pharmaceutical manufacturing, quality and helping to ensure a more reliable supply of high-quality medicines.”

He was honored in 2013 by Parenteral Drug Association (PDA), naming an annual award the Martin VanTrieste Pharmaceutical Science Award. He has delivered numerous presentations and authored articles on pharmaceutical quality and the security and robustness of supply chain.

Mr. VanTrieste earned a Pharmacy degree in 1983 from Temple University School of Pharmacy.